Senti Biosciences Statistics
Total Valuation
SNTI has a market cap or net worth of $20.77 million. The enterprise value is $33.24 million.
Important Dates
The last earnings date was Friday, March 27, 2026, before market open.
| Earnings Date | Mar 27, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
SNTI has 26.29 million shares outstanding. The number of shares has increased by 389.20% in one year.
| Current Share Class | 26.29M |
| Shares Outstanding | 26.29M |
| Shares Change (YoY) | +389.20% |
| Shares Change (QoQ) | +4.39% |
| Owned by Insiders (%) | 0.78% |
| Owned by Institutions (%) | 7.09% |
| Float | 9.72M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 944.20 |
| Forward PS | n/a |
| PB Ratio | 4.37 |
| P/TBV Ratio | 3.72 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 1,511.06 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.67, with a Debt / Equity ratio of 5.17.
| Current Ratio | 1.67 |
| Quick Ratio | 1.29 |
| Debt / Equity | 5.17 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -218.08% and return on invested capital (ROIC) is -61.31%.
| Return on Equity (ROE) | -218.08% |
| Return on Assets (ROA) | -48.89% |
| Return on Invested Capital (ROIC) | -61.31% |
| Return on Capital Employed (ROCE) | -156.53% |
| Weighted Average Cost of Capital (WACC) | 6.68% |
| Revenue Per Employee | $647 |
| Profits Per Employee | -$1.81M |
| Employee Count | 34 |
| Asset Turnover | 0.00 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -77.74% in the last 52 weeks. The beta is 2.13, so SNTI's price volatility has been higher than the market average.
| Beta (5Y) | 2.13 |
| 52-Week Price Change | -77.74% |
| 50-Day Moving Average | 0.95 |
| 200-Day Moving Average | 1.54 |
| Relative Strength Index (RSI) | 33.20 |
| Average Volume (20 Days) | 114,779 |
Short Selling Information
The latest short interest is 751,516, so 2.86% of the outstanding shares have been sold short.
| Short Interest | 751,516 |
| Short Previous Month | 813,632 |
| Short % of Shares Out | 2.86% |
| Short % of Float | 7.73% |
| Short Ratio (days to cover) | 6.21 |
Income Statement
In the last 12 months, SNTI had revenue of $22,000 and -$61.44 million in losses. Loss per share was -$2.73.
| Revenue | 22,000 |
| Gross Profit | 22,000 |
| Operating Income | -58.30M |
| Pretax Income | -61.44M |
| Net Income | -61.44M |
| EBITDA | -54.67M |
| EBIT | -58.30M |
| Loss Per Share | -$2.73 |
Full Income StatementBalance Sheet
The company has $16.42 million in cash and $28.89 million in debt, with a net cash position of -$12.47 million or -$0.47 per share.
| Cash & Cash Equivalents | 16.42M |
| Total Debt | 28.89M |
| Net Cash | -12.47M |
| Net Cash Per Share | -$0.47 |
| Equity (Book Value) | 5.59M |
| Book Value Per Share | 0.18 |
| Working Capital | 9.30M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$43.44 million and capital expenditures -$196,000, giving a free cash flow of -$43.64 million.
| Operating Cash Flow | -43.44M |
| Capital Expenditures | -196,000 |
| Depreciation & Amortization | 3.64M |
| Net Borrowing | n/a |
| Free Cash Flow | -43.64M |
| FCF Per Share | -$1.66 |
Full Cash Flow StatementMargins
| Gross Margin | 100.00% |
| Operating Margin | -265,018.18% |
| Pretax Margin | -279,263.64% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
SNTI does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -389.20% |
| Shareholder Yield | -389.20% |
| Earnings Yield | -295.77% |
| FCF Yield | -210.09% |
Analyst Forecast
The average price target for SNTI is $9.00, which is 1,039.10% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $9.00 |
| Price Target Difference | 1,039.10% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 4 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | -48.31% |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on July 18, 2024. It was a reverse split with a ratio of 1:10.
| Last Split Date | Jul 18, 2024 |
| Split Type | Reverse |
| Split Ratio | 1:10 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 1 |
